A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Board Meeting of ADS Diagnostic ....
Awaiting price reaction for this filing.
ADS Diagnostic Limited has informed BSE that a Board of Directors meeting is scheduled for 29th May 2026 to consider and approve the Audited Financial Results for the quarter ended 31st March 2026. This is a routine regulatory filing under SEBI Listing Regulations, requiring advance notice before any board meeting that discusses financial results. The meeting will be held at the company's registered office in New Delhi or via Zoom. No specific financial details or agenda items beyond the quarterly results approval have been disclosed in this notice.
This is a standard procedural filing announcing an upcoming board meeting. The actual impact on the stock will only be known after the results are approved and disclosed, typically within 30 days of quarter end. Investors should watch for the results announcement expected after 29th May 2026.